Get Up To Speed on Medicare Inflation Rebates: HPM Issues Memorandum Summarizing CMS Final Rule; HPM and Riparian to Co-Host Webinar
February 12, 2025Drug manufacturers won’t be receiving their first invoices for Medicare Part B and Part D inflation rebates until later this year, but rebates have been accruing since first quarter 2023 for Part B rebates and October 2022 for Part D rebates. To help our readers learn more about these rebates before they confront the first invoices, we’ve prepared a memo summarizing CMS’ final rule on the two Medicare inflation rebate programs, which was issued on December 9, 2024. The memo is available here.
In addition, on Tuesday, February 18, Hyman, Phelps & McNamara will be co-hosting a webinar on the CMS final rule with Riparian LLC. The webinar will explore the legal and operational considerations for drug manufacturers. Among other topics, the webinar will discuss Part B and Part D inflation rebate calculations, invoicing and reconciliation timelines and processes, and CMS enforcement tools. More details are available below.
For those readers who lack the time or patience to read our memo or to listen to the webinar, a summary chart comparing the Part B and Part D programs is available here.
Webinar Details:
Date: Tuesday, February 18, 2025
Time: 12:00 PM to 1:30 PM ET
Presenters:
- Alan Kirschenbaum, Director, HPM
- Sophia Gaulkin, Associate, HPM
- Cynthia Hwang, General Manager, Riparian LLC
- Susan Dunne, Managing Director, Riparian LLC
Please click here to register. Once you register, you’ll receive instructions by email on how to access the webinar. We hope you’ll join us!